About 12 results found for searched term "MS78" (0.11 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1682 | BMS-777607 | c-Met |
| BMS 817378; CAS# 1025720-94-8 | ||
| BMS-777607 is a selective and potent small-molecule met kinase inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, respectively. | ||
| M3485 | BMS-378806 | HIV Protease |
| BMS 806 | ||
| BMS-378806 selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus. | ||
| M7668 | BMS-646786 | P2 Receptor |
| BPTU | ||
| BMS-646786 is a potent and specific inhibitor of P2Y1 purinergic receptor that inhibits ADP-mediated platelet aggregation in human blood samples. | ||
| M7671 | BMS-823778 | Hydroxysteroid dehydrogenase |
| BMS-823778 is an orally available potent and selective inhibitor of 11-β-hydroxysteroid-dehyd |
||
| M8769 | Tasimelteon | Melatonin Receptor |
| BMS-214778; VEC-162 | ||
| Tasimelteon (BMS-214778) is a Dual Melatonin Receptor Agonist (DMRA) recently approved (Hetlioz) for the treatment of Non-24-hour sleep–wake disorder, a disorder primarily found in the totally blind, where a lack of normal synchronization between the 24-hour light–dark cycle and the endogenous circadian rhythm causes it to drift out of alignment with conventional sleep–wake schedules. | ||
| M9397 | MS4078 | ALK |
| MS4078 is a PROTAC degrader of ALK which potently decreases cellular levels of oncogenic active ALK fusion proteins in SU-DHL-1 lymphoma and NCI-H2228 lung cancer cells. | ||
| M14451 | BMS-978587 | IDO |
| IDO-IN-4 | ||
| BMS-978587 (IDO-IN-4) is an indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor. | ||
| M14461 | BMS-779788 | Liver X Receptor |
| EXEL04286652; XL-652; BMS-788 | ||
| BMS-779788 is a LXR partial agonist with IC50 values of 68 nM for LXRα and 14 nM for LXRβ. | ||
| M21207 | BMS-986278 | LPL Receptor |
| BMS-986278 is a potentially first-in-class, potent, small molecule LPA1 antagonist with a Kb of 6.9 nM that can be used in studies related to lung injury and pulmonary fibrosis. | ||
| M25151 | Beludavimab | Anti-infection |
| BMS 4182137; VIR 7832 | ||
| Beludavimab (BMS 4182137; VIR 7832) is a monoclonal antibody targeting the spike glycoprotein of SARS-CoV-2. Beludavimab binds to recombinant spike protein receptor-binding domain (S-RBD) with an EC50 value of 14.9 ng/mL and a Kd of 0.21 nM. | ||
| M41719 | MS78 | p53 |
| MS78 is an acetylation targeting chimera (AceTAC) that acetylates the p53 tumor suppressor protein. | ||
| M54763 | BMS-817378 | c-Met |
| BMS817378 | ||
| BMS-817378 is a potent and selective inhibitor of MET with IC50 of 1.7 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
